- Home
- WHLR vs GTBP Comparison
WHLR vs GTBP Comparison
Compare WHLR & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHLR | GTBP |
|---|---|---|
| Founded | 2011 | 1965 |
| Country | United States | United States |
| Employees | 49 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 12.1M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | WHLR | GTBP |
|---|---|---|
| Price | $1.40 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 157.4K | ★ 783.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.75 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.65 | $0.39 |
| 52 Week High | $10.05 | $3.73 |
Technical Indicators
Market Signals| Indicator | WHLR | GTBP |
|---|---|---|
| Relative Strength Index (RSI) | 35.41 | 35.31 |
| Support Level | N/A | $0.41 |
| Resistance Level | $2.25 | $0.59 |
| Average True Range (ATR) | 0.19 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 1.18 | 28.63 |
Price Performance
Historical ComparisonAbout WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Cypress Shopping Center in Boiling Springs, South Carolina, and others.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.